# Sodium Pyruvate Therapy in COPD Patients

> **NCT00262613** · PHASE2 · COMPLETED · sponsor: **Emphycorp** · enrollment: 60 (—)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** sodium pyruvate in 0.9% sodium chloride solution

## Key facts

- **NCT ID:** NCT00262613
- **Lead sponsor:** Emphycorp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262613, "Sodium Pyruvate Therapy in COPD Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00262613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*